The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Idecabtagene vicleucel (ide-cel, bb2121), a BCMA-directed CAR T-cell therapy: Qualitative analyses of pretreatment patient interviews in the KarMMa trial.
 
Julia Braverman
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Olga Moshkovich
Employment - ICON Clinical Research; ICON Clinical Research; private practice (I)
Stock and Other Ownership Interests - ICON Clinical Research; ICON Clinical Research
Research Funding - ICON Clinical Research (Inst)
 
Matthew Miera
Employment - ICON Clinical Research
 
Selam Shah
Employment - ICON Clinical Research
 
Triza Brion
Employment - ICON Clinical Research
 
Jennifer Devlen
Employment - ICON Clinical Research
Stock and Other Ownership Interests - ICON Clinical Research
 
Kristen Hege
Employment - Bristol-Myers Squibb
Leadership - Arcus Biosciences; Mersana
Stock and Other Ownership Interests - Bristol-Myers Squibb
Consulting or Advisory Role - Arcus Biosciences
Research Funding - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb
Other Relationship - Society for Immunotherapy of Cancer
 
Timothy Brandon Campbell
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb